Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2013-11-12
2021-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* current blood glucose (mmol/L)
* target blood glucose (mmol/L)
* insulin-to-carbohydrate ratio (grams of carbohydrate per 1 unit of insulin)
* total grams of carbohydrate in meals
* insulin sensitivity factor (reduction in glucose per 1 unit of insulin)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Assessment of a Novel Advanced Bolus Calculator for Type 1 Diabetes 5
NCT03963219
Comparison of the Management of Post-prandial Hyperglycemia by Multiple Bolus Calculators
NCT01050868
Efficacy of Automated Bolus Calculation in Type 2 Diabetes
NCT02887898
Bolus Insulin Card Calculator Randomised Controlled Study
NCT00748137
Proof of Concept - Identification of Patient-specific Parameters for Bolus Calculators for Type 1 Diabetes
NCT03414320
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The end-product is therefore a subject specific insulin bolus calculator that continues to improve with time. The project utilises commercially available glucose sensors and smartphones (iPhone), integrated with a novel algorithm for insulin bolus calculation. The aim of the ABC4D is to minimise high and low glucose excursions which are associated with the complications of diabetes including blindness, kidney failure, nerve damage and cardiovascular disease.
An interim analysis was conducted in Phase 4 after 25 participants completed the study (in line with the protocol) and it was agreed to stop the study at this stage. A further protocol amendment was approved by REC/MHRA to commence ABC4D phase 5 (different CT.gov number: NCT03963219).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phase 4: Intervention (ABC4D)
Advanced Bolus Calculator for Type Diabetes (ABC4D)
ABC4D
Advanced Bolus Calculator for Type 1 Diabetes (ABC4D) to calculate pre-meal insulin boluses
Phase 4 Control: Standard bolus calculator
Standard bolus calculator
Standard bolus calculator
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ABC4D
Advanced Bolus Calculator for Type 1 Diabetes (ABC4D) to calculate pre-meal insulin boluses
Standard bolus calculator
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of T1DM for \> 1 year
* On MDI using a basal-bolus insulin regime
* Structured education in previous 3 years
* HbA1c ≤ 86mmol/mol
* No severe hypoglycaemia (defined as needing 3rd party assistance) in previous year
Exclusion Criteria
* Pregnant or planning pregnancy
* Breastfeeding
* Enrolled in other clinical trials
* Have active malignancy or under investigation for malignancy
* Addison's Disease
* Gastroparesis
* Autonomic neuropathy
* Concomitant use of GLP-1 analogues and gliptins
* Visual impairment
* Reduced manual dexterity
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imperial College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Desmond Johnston, F.Med.Sci
Role: PRINCIPAL_INVESTIGATOR
Imperial College London
Nick Oliver, MRCP
Role: PRINCIPAL_INVESTIGATOR
Imperial College London
Monika Reddy
Role: PRINCIPAL_INVESTIGATOR
Imperial College London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Imperial College London, Imperial College Healthcare NHS Trust
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Reddy M, Pesl P, Xenou M, Toumazou C, Johnston D, Georgiou P, Herrero P, Oliver N. Clinical Safety and Feasibility of the Advanced Bolus Calculator for Type 1 Diabetes Based on Case-Based Reasoning: A 6-Week Nonrandomized Single-Arm Pilot Study. Diabetes Technol Ther. 2016 Aug;18(8):487-93. doi: 10.1089/dia.2015.0413. Epub 2016 May 19.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
Our research website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13SM0091
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.